BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 31444548)

  • 21. GATORopathies: The role of amino acid regulatory gene mutations in epilepsy and cortical malformations.
    Iffland PH; Carson V; Bordey A; Crino PB
    Epilepsia; 2019 Nov; 60(11):2163-2173. PubMed ID: 31625153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of somatic mutational events in the pathogenesis of epilepsy.
    Iffland PH; Crino PB
    Curr Opin Neurol; 2019 Apr; 32(2):191-197. PubMed ID: 30762606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward a better definition of focal cortical dysplasia: An iterative histopathological and genetic agreement trial.
    Blümcke I; Coras R; Busch RM; Morita-Sherman M; Lal D; Prayson R; Cendes F; Lopes-Cendes I; Rogerio F; Almeida VS; Rocha CS; Sim NS; Lee JH; Kim SH; Baulac S; Baldassari S; Adle-Biassette H; Walsh CA; Bizzotto S; Doan RN; Morillo KS; Aronica E; Mühlebner A; Becker A; Cienfuegos J; Garbelli R; Giannini C; Honavar M; Jacques TS; Thom M; Mahadevan A; Miyata H; Niehusmann P; Sarnat HB; Söylemezoglu F; Najm I
    Epilepsia; 2021 Jun; 62(6):1416-1428. PubMed ID: 33949696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.
    Baulac S; Ishida S; Marsan E; Miquel C; Biraben A; Nguyen DK; Nordli D; Cossette P; Nguyen S; Lambrecq V; Vlaicu M; Daniau M; Bielle F; Andermann E; Andermann F; Leguern E; Chassoux F; Picard F
    Ann Neurol; 2015 Apr; 77(4):675-83. PubMed ID: 25623524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal cortical dysplasia: Updates.
    Pinheiro J; Honavar M
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S189-S197. PubMed ID: 35562149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTOR signaling in epilepsy: insights from malformations of cortical development.
    Crino PB
    Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly.
    Arai A; Saito T; Hanai S; Sukigara S; Nabatame S; Otsuki T; Nakagawa E; Takahashi A; Kaneko Y; Kaido T; Saito Y; Sugai K; Sasaki M; Goto Y; Itoh M
    Brain Res; 2012 Aug; 1470():89-97. PubMed ID: 22759905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technological and computational approaches to detect somatic mosaicism in epilepsy.
    Boßelmann CM; Leu C; Lal D
    Neurobiol Dis; 2023 Aug; 184():106208. PubMed ID: 37343892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Space-Time Continuum of Cortical Dysplasia.
    Jansen LA
    Epilepsy Curr; 2019 Jan; 19(1):54-56. PubMed ID: 30838928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE.
    Elziny S; Crino PB; Winawer M
    Neurobiol Dis; 2023 Oct; 187():106299. PubMed ID: 37739137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of brain somatic variation in epilepsy-associated developmental lesions.
    Bedrosian TA; Miller KE; Grischow OE; Schieffer KM; LaHaye S; Yoon H; Miller AR; Navarro J; Westfall J; Leraas K; Choi S; Williamson R; Fitch J; Kelly BJ; White P; Lee K; McGrath S; Cottrell CE; Magrini V; Leonard J; Pindrik J; Shaikhouni A; Boué DR; Thomas DL; Pierson CR; Wilson RK; Ostendorf AP; Mardis ER; Koboldt DC
    Epilepsia; 2022 Aug; 63(8):1981-1997. PubMed ID: 35687047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epilepsy in the mTORopathies: opportunities for precision medicine.
    Moloney PB; Cavalleri GL; Delanty N
    Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy.
    Ribierre T; Deleuze C; Bacq A; Baldassari S; Marsan E; Chipaux M; Muraca G; Roussel D; Navarro V; Leguern E; Miles R; Baulac S
    J Clin Invest; 2018 Jun; 128(6):2452-2458. PubMed ID: 29708508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilateral holohemispheric central nervous system lesions associated with medically refractory epilepsy in the pediatric population: a retrospective series of hemimegalencephaly and Rasmussen's encephalitis.
    Wang DD; Benkli B; Auguste KI; Garcia PA; Sullivan J; Barkovich AJ; Chang EF; Tihan T
    J Neurosurg Pediatr; 2014 Dec; 14(6):573-84. PubMed ID: 25303156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes.
    Krochmalnek E; Accogli A; St-Onge J; Addour-Boudrahem N; Prakash G; Kim SH; Brunette-Clement T; Alhajaj G; Mougharbel L; Bruneau E; Myers KA; Dubeau F; Karamchandani J; Farmer JP; Atkinson J; Hall J; Chantal Poulin C; Rosenblatt B; Lafond-Lapalme J; Weil A; Fallet-Bianco C; Albrecht S; Sonenberg N; Riviere JB; Dudley RW; Srour M
    Neurol Genet; 2023 Dec; 9(6):e200103. PubMed ID: 37900581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by MTOR mosaicism.
    Wang Y; Yu T; Blümcke I; Cai Y; Sun K; Gao R; Wang Y; Fu Y; Wang W; Wang Y; Zhang G; Piao Y
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12874. PubMed ID: 36544434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
    Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive clinico-pathological and genetic evaluation of bottom-of-sulcus focal cortical dysplasia in patients with difficult-to-localize focal epilepsy.
    Ying Z; Wang I; Blümcke I; Bulacio J; Alexopoulos A; Jehi L; Bingaman W; Gonzalez-Martinez J; Kobow K; Niestroj LM; Lal D; Koelble K; Najm I
    Epileptic Disord; 2019 Feb; 21(1):65-77. PubMed ID: 30782578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.
    Lee JH; Huynh M; Silhavy JL; Kim S; Dixon-Salazar T; Heiberg A; Scott E; Bafna V; Hill KJ; Collazo A; Funari V; Russ C; Gabriel SB; Mathern GW; Gleeson JG
    Nat Genet; 2012 Jun; 44(8):941-5. PubMed ID: 22729223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.